These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 7651435

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Heterologous C-terminal sequences disrupt transcriptional activation and oncogenesis by p59v-rel.
    Diehl JA, Hannink M.
    J Virol; 1993 Dec; 67(12):7161-71. PubMed ID: 8230438
    [Abstract] [Full Text] [Related]

  • 9. Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies.
    Fracchiolla NS, Lombardi L, Salina M, Migliazza A, Baldini L, Berti E, Cro L, Polli E, Maiolo AT, Neri A.
    Oncogene; 1993 Oct; 8(10):2839-45. PubMed ID: 8378093
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
    Hatada EN, Nieters A, Wulczyn FG, Naumann M, Meyer R, Nucifora G, McKeithan TW, Scheidereit C.
    Proc Natl Acad Sci U S A; 1992 Mar 15; 89(6):2489-93. PubMed ID: 1532257
    [Abstract] [Full Text] [Related]

  • 15. NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule.
    Scheinman RI, Beg AA, Baldwin AS.
    Mol Cell Biol; 1993 Oct 15; 13(10):6089-101. PubMed ID: 8413211
    [Abstract] [Full Text] [Related]

  • 16. Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-kappa B/Rel family.
    Pan J, McEver RP.
    J Biol Chem; 1995 Sep 29; 270(39):23077-83. PubMed ID: 7559449
    [Abstract] [Full Text] [Related]

  • 17. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner.
    Nolan GP, Fujita T, Bhatia K, Huppi C, Liou HC, Scott ML, Baltimore D.
    Mol Cell Biol; 1993 Jun 29; 13(6):3557-66. PubMed ID: 8497270
    [Abstract] [Full Text] [Related]

  • 18. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
    Stütz AM, Woisetschläger M.
    J Immunol; 1999 Oct 15; 163(8):4383-91. PubMed ID: 10510379
    [Abstract] [Full Text] [Related]

  • 19. I kappa B alpha can localize in the nucleus but shows no direct transactivation potential.
    Cressman DE, Taub R.
    Oncogene; 1993 Sep 15; 8(9):2567-73. PubMed ID: 8361766
    [Abstract] [Full Text] [Related]

  • 20. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
    Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin AS.
    Oncogene; 2000 Feb 24; 19(9):1123-31. PubMed ID: 10713699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.